U.S. Markets close in 1 hr 20 mins

Johnson & Johnson (JNJ)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
133.10+0.47 (+0.35%)
As of 2:40PM EDT. Market open.
People also watch
PGMRKKOPFEXOM
Full screen
Previous Close132.63
Open132.28
Bid133.44 x 200
Ask133.47 x 500
Day's Range132.19 - 133.65
52 Week Range109.32 - 137.08
Volume2,081,555
Avg. Volume5,552,395
Market Cap357.24B
Beta0.64
PE Ratio (TTM)22.37
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield3.36 (2.53%)
Ex-Dividend Date2017-08-25
1y Target EstN/A
Trade prices are not sourced from all markets
  • The Wall Street Journal3 minutes ago

    [$$] Johnson & Johnson Hit With $417 Million Verdict in Baby Powder Case

    A jury awarded a woman with ovarian cancer $417 million Monday in a case against Johnson & Johnson, the latest hit to the pharmaceutical company in widespread litigation over the alleged harms of its baby ...

  • Financial Times13 minutes ago

    [$$] Johnson & Johnson unit speaks out at planned death row drug use

    Johnson & Johnson, the world's largest healthcare company, has hit out at plans by the US state of Florida to execute a prisoner on death row using an experimental lethal injection containing a drug it ...

  • Reuters22 minutes ago

    J&J ordered to pay $417 mln in trial over talc cancer risks

    Johnson & Johnson on Monday was ordered by a California jury to pay $417 million to a woman who claimed she developed ovarian cancer after using the company's talc-based products like Johnson's Baby Powder for feminine hygiene. The Los Angeles Superior Court jury's verdict in favor of California resident Eva Echeverria was the largest to date in lawsuits alleging J&J failed to adequately warn consumers about the cancer risks of talc-based products.